Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab

被引：36

作者：

de Klerk, Timothy A. ^{[1
]}

Sharma, Vibha ^{[2
]}

Arkwright, Peter D. ^{[2
]}

Biswas, Susmito ^{[1
]}

机构：

[1] Manchester Royal Eye Hosp, Manchester M13 9WH, Lancs, England

[2] Univ Manchester, Dept Paediat Allergy & Immunol, Manchester, Lancs, England

来源：

JOURNAL OF AAPOS | 2013年 / 17卷 / 03期

关键词：

D O I：

10.1016/j.jaapos.2012.12.153

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

A 12-year-old boy with severe mixed limbal and palpebral vernal keratoconjunctivitis experienced persistent ocular symptoms despite treatment with topical corticosteroids or cyclosporine. Signs and symptoms resolved completely with monthly subcutaneous omalizumab, an immunomodulating biologic agent. To our knowledge, this is the first report of its use as a monotherapy agent to treat vernal keratoconjunctivitis.

引用

页码：305 / 306

页数：2

共 6 条

[1] Vernal keratoconjunctivitis revisited - A case series of 195 patients with long-term follow-up [J].

Bonini, S ;

Lambiase, A ;

Marchi, S ;

Pasqualetti, P ;

Zuccaro, O ;

Rama, P ;

Magrini, L ;

Juhas, T ;

Bucci, MG .

OPHTHALMOLOGY, 2000, 107 (06) :1157-1163

[2] Effect of omalizumab on symptoms of seasonal allergic rhinitis - A randomized controlled trial [J].

Casale, TB ;

Condemi, J ;

LaForce, C ;

Nayak, A ;

Rowe, M ;

Watrous, M ;

McAlary, M ;

Fowler-Taylor, A ;

Racine, M ;

Gupta, N ;

Fick, R ;

Della Cioppa, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23) :2956-2967

[3] Safety and tolerability of omalizumab [J].

Corren, J. ;

Casale, T. B. ;

Lanier, B. ;

Buhl, R. ;

Holgate, S. ;

Jimenez, P. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (06) :788-797

[4] Omalizumab. An option in vernal keratoconjunctivitis? [J].

Sanchez, J. ;

Cardona, R. .

ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2012, 40 (05) :319-320

[5] Anti-IgE for chronic asthma in adults and children [J].

Walker, S. ;

Monteil, M. ;

Phelan, K. ;

Lasserson, T. J. ;

Walters, E. H. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)

[6] Omalizumab: a future innovation for treatment of severe ocular allergy? [J].

Williams, PB ;

Sheppard, JD .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (12) :1603-1609

← 1 →